DOCGO INC Stock Price, News & Analysis

DocGo (NASDAQ:DCGO) has announced a new multi-year preferred provider agreement with Fresenius Medical Care, the largest kidney dialysis treatment provider in the U.S. The collaboration, effective May 1, 2023, enhances DocGo's offerings in remote patient monitoring, chronic care management, and urgent care services. This partnership builds on a relationship established in 2019, allowing nephrologists to better manage the health of approximately 780,000 end-stage renal disease patients and millions of chronic kidney disease patients in the U.S. DocGo aims to deliver proactive health care, reducing hospitalization risks and improving patient outcomes through advanced technology and integration with Fresenius Medical Care's resources.

DocGo, a leading provider of last-mile mobile health services, will announce its first-quarter financial results for the period ending March 31, 2023, after markets close on May 8, 2023. A conference call for investors and analysts is scheduled for 5:00 PM EDT on the same day.

The company aims to disrupt traditional healthcare delivery by providing affordable and quality care to patients directly at home or work, leveraging innovative technology and certified health professionals. Their services include telehealth and integrated medical transport, aiming to enhance patient care while improving operational efficiencies for healthcare providers.

DocGo Inc (NASDAQ: DCGO) announced the participation of President and COO Lee Bienstock in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on April 20 at 2:15 PM ET. The event aims to showcase the company's innovative approach in providing last-mile mobile health services, enhancing patient care through technology and certified health professionals. DocGo's services aim to improve healthcare delivery by bridging physical and virtual care, empowering telehealth capabilities in patients' homes or workplaces. A webcast will be accessible on DocGo's investor relations website.

DocGo (NASDAQ: DCGO) announced that CEO Anthony Capone will join a panel at HIMSS23 in Chicago on April 18, from 3:00 PM to 4:00 PM. The panel, led by Life365’s Kent Dicks, will discuss the "Virtual First Approach to Augment Consumer Care Delivery at Home." Capone aims to explore virtual care technology solutions to enhance patient engagement and outcomes. This event highlights the growing importance of virtual care in healthcare delivery. For more details, please register for HIMSS23 here.

DocGo (Nasdaq:DCGO) reported substantial growth in new business contracts, securing over $180 million in revenue contracts and expansions for the next three years since January 2023. Key partnerships include a not-for-profit health system in Philadelphia, a hospital network in Long Island, and federally funded hospitals. The company plans to enhance its mobile health services and will hire hundreds of clinicians while expanding its fleet by 100 vehicles, promoting sustainable practices through its Zero Emission initiative. All contracts are expected to roll out by the end of Q3 2023.

DocGo Inc. (Nasdaq: DCGO) reported a significant revenue increase in 2022, reaching $440.5 million, a 38% rise from $318.7 million in 2021. Mobile Health revenue grew to $325.9 million, marking a 39% increase, while net income rose by 60% to $30.7 million. The company projects 2023 revenue between $500-$510 million, a 14%-16% growth over 2022. In Q4 2022, total revenue was $108.8 million, down from $121.3 million in Q4 2021, impacted by reduced COVID testing revenue. DocGo announced new partnerships and secured a $90 million line of credit, emphasizing continued growth in mobile health services.

DocGo Inc (NASDAQ: DCGO), a leader in mobile health services, announced that CEO Anthony Capone will present at the Cowen 43rd Annual Healthcare Conference in Boston on March 7 at 2:10 PM ET. Additionally, Mr. Capone will present virtually at the Oppenheimer 33rd Annual Healthcare Conference on March 15 at 9:20 AM ET. Investors can access the webcasts on DocGo's investor relations website.

DocGo is transforming healthcare by providing high-quality, affordable mobile care, supported by innovative technology and a team of certified professionals, enhancing patient care and operational efficiencies.

DocGo (Nasdaq: DCGO) announced plans to report its fourth-quarter and full-year results for the period ended December 31, 2022 on March 13, after market close. A conference call will follow at 5:00pm ET, accessible via U.S. and international lines. DocGo specializes in last-mile mobile health services, leveraging technology and certified professionals to enhance patient care and operational efficiency. The company's innovative approach bridges the gap between physical and virtual healthcare, aiming to provide affordable, high-quality care at home or in the workplace.

DocGo (NASDAQ: DCGO) has partnered with Redirect Health to provide on-demand, urgent mobile care services in New Jersey and New York. This collaboration aims to reduce emergency room visits and enhance patient care through DocGo's in-home services. Both companies share a mission to improve healthcare accessibility and affordability. The partnership will deliver mobile health services to Redirect Health's members and is expected to expand further in 2023. This initiative is part of DocGo's ongoing commitment to transform healthcare delivery through tech-enabled solutions.